MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12020-025-04548-6

Медицинская библиотека · Endocrine · 2026

Comparative evaluation of dynamic risk stratification according to ATA 2015 and ATA 2025 in low-risk differentiated thyroid cancer without radioiodine ablation.

Fernández Velasco Pablo, Peciña Melgosa Paula, Torres Torres Beatriz, Torres Morientes Luis Miguel, Fernández Rodríguez Ana, Alonso Mesonero Marta, de Uribe Viloria Marta, Álvarez Quiñones María, Santos Pérez Jaime, de Luis Román Daniel, Diaz-Soto Gonzalo

СтатьяСравнительное исследованиеПеревод пока не подготовлен

Аннотация

PURPUSE: To compare dynamic risk stratification (DRS) according to the 2015 American Thyroid Association-Momesso et al. 2016 extension (ATA2015-M) and the 2025 ATA update in low-risk differentiated thyroid cancer (DTC) managed without radioactive iodine (I-131), and to explore the role of an intermediate thyroglobulin (Tg) cutoff of 1 ng/mL.

METHODS

We conducted a retrospective analysis of a prospectively collected cohort of 74 low-risk DTC patients treated with total thyroidectomy (n = 55) or hemithyroidectomy (n = 19) between 2020 and 2024. Clinical, histopathological, and biochemical data were collected. DRS was assessed at the first follow-up visit (6 months after surgery) and at the last visit (median follow-up 27 months [IQR 16–41]) using ATA2015-M and ATA2025 criteria. An exploratory analysis applying a Tg cutoff of 1 ng/mL was performed.

RESULTS

According to ATA2015-M, excellent response (ER) rates in total thyroidectomy patients increased from 49.2% at baseline to 52.8% at final follow-up. In contrast, ATA2025 classified 89.1% as ER at baseline and 98.2% at final follow-up (p < 0.001). Using the intermediate cutoff of 1 ng/mL, ER rates were 80.0% and 89.1%, respectively. Reclassification to ER under ATA2025 was primarily driven by anti-thyroglobulin antibody (TgAb) negativization, as Tg values remained stable and below the new 2.5 ng/mL threshold. No structural incomplete responses were observed.

CONCLUSION

ATA2025 criteria substantially increase ER classification in low-risk DTC patients managed without I-131 compared with ATA2015-M. A 1 ng/mL Tg cutoff may provide a more realistic representation of clinical practice. The dynamic trend of TgAb, rather than their presence alone, is a key determinant for reclassification during follow-up.

Для цитирования: Fernández Velasco Pablo, Peciña Melgosa Paula, Torres Torres Beatriz, Torres Morientes Luis Miguel, Fernández Rodríguez Ana, Alonso Mesonero Marta, de Uribe Viloria Marta, Álvarez Quiñones María, Santos Pérez Jaime, de Luis Román Daniel, Diaz-Soto Gonzalo. Comparative evaluation of dynamic risk stratification according to ATA 2015 and ATA 2025 in low-risk differentiated thyroid cancer without radioiodine ablation.. Endocrine. 2026. DOI: 10.1007/s12020-025-04548-6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.